uspto-grants-2013_09 · 10.6084/m9.figshare.5104873.v1 · US08536179B2
查看HCID67469117
N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-3-methyl-6-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide
N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-methyl-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylindole-4-carboxamide
C31H38N6O2526.7 g/mol
IDENTITY
结构与身份
- 标准SMILES
- Cc1cc(C)c(CNC(=O)c2cc(-c3ccc(N4CCN(C)CC4)nc3)cc3c2c(C)cn3C(C)C)c(=O)[nH]1
- InChIKey
- HRDQQHUKUIKFHT-UHFFFAOYSA-N
- 分子式
- C31H38N6O2
- 平均分子量
- 526.7 g/mol
- 单同位素质量
- 526.30562448
COMPUTED
结构计算性质
- XLogP
- 3.8
- 极性表面积
- 82.5 Ų
- 氢键供体
- 2
- 氢键受体
- 5
- 可旋转键
- 6
- 重原子
- 39
- 形式电荷
- 0
- 复杂度
- 984
ALIASES
名称与别名
GSK5031346572-63-1N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-3-methyl-6-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamideGSK-503GSK 503MFCD28405142N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-methyl-6-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-1-propan-2-ylindole-4-carboxamideGSK-503?EZH2 inhibitororb1226484orb1307466SCHEMBL2595868CHEMBL3909511SCHEMBL29351554EX-A613GSK503?CHEBI:231340HRDQQHUKUIKFHT-UHFFFAOYSA-NGLXC-06400GSK2635503Cs7804
REACTIONS
参与反应
uspto-grants-2016_09 · 10.6084/m9.figshare.5104873.v1 · US09446041B2
查看uspto-grants-2015_08 · 10.6084/m9.figshare.5104873.v1 · US09114141B2
查看uspto-grants-2016_01 · 10.6084/m9.figshare.5104873.v1 · US09242962B2
查看uspto-grants-2015_03 · 10.6084/m9.figshare.5104873.v1 · US08975291B2
查看uspto-grants-2016_08 · 10.6084/m9.figshare.5104873.v1 · US09402836B2
查看